Stem cell therapy may prevent PAD-related amputations

Patients with critical limb ischemia who received injections of stem cells derived from their bone marrow had a lower risk of amputation and death than patients who were not treated with the therapy in a Phase II clinical trial.

View Full Article in:

Stem Cells Improve Outlook for Severe PAD - DailyRx.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Senior Manager, Compliance
Stryker
Fremont, CA
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA